Predictors of hypoglycemia in insulin-treated patients with type 2 diabetes mellitus in Basrah

Table 5 Relation of hypoglycemia during the last 3 mo with availability, frequency of self-monitoring of blood glucose, common co-morbidities, and concomitant medication use (other than OHD)

	Hypoglycemia in the last 3 mo		Total (n)	P value
	Yes n (% )	No n (% )
Availability of SMBG
Available and used	124 (75.2)	41 (24.8)	165	0.996
Not available	102 (75.6)	33 (24.4)	135
Available and not used	27 (75.0)	9 (25.0)	36
Frequency of SMBG use
Once/mo	19 (79.2)	5 (20.8)	24	0.164
1-2 times/wk	48 (67.6)	23 (32.4)	71
Once daily	23 (74.2)	8 (25.8)	31
Twice daily	8 (88.9)	1 (11.1)	9
Thrice daily	2 (50.0)	2 (50.0)	4
According to patients condition	25 (89.3)	3 (10.7)	28
Common co-morbidities
HTN	106 (72.1)	41 (27.9)	147	0.232
IHD	50 (86.2)	8 (13.8)	58	0.034
CVA	15 (75.0)	5 (25.0)	20	0.975
Amputation	7 (70.0)	3 (30.0)	10	0.693
Diabetic foot	72 (79.1)	19 (20.9)	91	0.322
CKD	66 (73.3)	24 (26.7)	90	0.614
PNP	235 (77.6)	68 (22.4)	303	0.004
Insulin use by other family members
At home	21 (80.8)	5 (19.2)	26	0.764
Outside home	42 (76.4)	13 (23.6)	55
Non	190 (74.5)	65 (25.5)	255
Concomitant medication use (other than OHD)
Yes	215 (74.1)	75 (25.9)	290	0.216

SMBG: Self-monitoring of blood glucose; HTN: Hypertension; IHD: Ischemic heart diseases; CVA: Cerebrovascular accidents; CKD: Chronic kidney disease; PNP: Peripheral neuropathy.